INHIBITION OF LACTATE DEHYDROGENASE 5 (LDH-5) BINDING, INCORPORATION, INTERNALIZATION AND/OR ENDOCYTOSIS TO IMMUNE CELLS

USPTO Patent Application US 2017/0029531 A1
Application Date: Feb. 2nd, 2017

ABSTRACT

Disclosed are methods of treating cancer in a subject including administering to the subject a therapeutic dose of an agent that inhibits LDH-5 binding to, incorporation, internalization and/or endocytosis into...
Application Number:
15/302,458
International Classification:
C07K 16/40 (20060101)
No Pictures Available

CLAIMS

What is claimed is:

1. A method of inhibiting, ameliorating, or treating cancer in a subject comprising: selecting a subject to receive a binding agent specific for Lactate dehydrogenase 5 (LDH-5), or selecting a subject to receive an anti-cancer therapy;providing to said subject an amount of a binding agent, which may be humanized, such as...

DESCRIPTION

INCORPORATION BY REFERENCE TO ANY PRIORITY APPLICATIONS

The present application claims the benefit of priority to U.S. Provisional Patent Application No. 61/977,500, filed Apr. 9, 2014 the entire disclosure of which is incorporated herein by reference in its entirety.
Back to Top